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Abstract
UL16 binding proteins (ULBPs) are ligands for the NK cell activating receptor NKG2D. A cDNA encoding a porcine ULBP-like protein
(PULBP) was cloned and the predicted amino acid sequence exhibited 35–52% identity to human ULBPs. Southern blot analysis suggested
that there is only one ULBP-like gene in the pig genome. Transcripts of PULBP and another potential NKG2D ligand, MIC2, were detected by
RT-PCR in a wide range of tissues. Recombinant PULBP-Fc and human ULBP2-Fc fusion proteins were made and used to examine PULBP
binding to porcine PBMCs and a human NK cell line (NKL cells). PULBP-Fc bound to a subpopulation of porcine PBMCs but not NKL
cells. Conversely, human ULBP2-Fc did not bind to porcine PBMCs but did stably interact with NKL cells.
© 2004 Elsevier Ltd. All rights reserved.
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1. Introduction
The human UL16 binding proteins (ULBPs) function as
activating ligands for the NK cell receptor NKG2D (Cosman
et al., 2001; Sutherland et al., 2002). Upon infection with
human cytomegalovirus, the viral protein UL16 binds some
ULBPs (ULBP1 and ULBP2) thereby preventing their cell-
surface expression as one mechanism for immune evasion
(Rolle et al., 2003). In humans, four members of this MHC
class I-extended gene family have been described (Cosman
 The nucleotide sequence data reported in this paper have been submitted
to the GenBank nucleotide sequence database and have been assigned the
accession number AY248037.
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et al., 2001; Jan et al., 2003). Human ULBP1–3 are GPI-
linked molecules while ULBP4 is a transmembrane pro-
tein. Members of the MHC class I-extended gene family,
human ULBP1–4 contain 1 and 2 domains, but not 3
(and they do not bind 2-microglobulin). The expression
of these molecules varies; ULBP4 has been reported to
be expressed predominantly in the skin (Jan et al., 2003)
while other ULBPs are expressed in a wide variety of tis-
sues including lung, liver, heart and testis (Cosman et al.,
2001). All four ULBPs are potent ligands for the activat-
ing NKG2D receptor found on NK cells, NKT cells, and
on a subset of CD8+ T cells. Ligands for NKG2D, like
the ULBPs, appear to have significant weight in the bal-
ance between activation and inhibition of NK cell activ-
ity (reviewed in Vivier et al., 2002). The interaction of
ULBPs with NKG2D is capable of activating NK cells
0161-5890/$ – see front matter © 2004 Elsevier Ltd. All rights reserved.
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even in the presence of inhibitory signals (Cosman et al.,
2001).
ULBP-like genes have also been identify in the mouse. In
mouse, these are known as the Raet1 gene family (retinoic
acid early transcripts 1) and include four highly related genes.
Raet1 gene product, RAE-1, and H60, another mouse ho-
mologue of ULBP (Cerwenka et al., 2000, 2002) are sim-
ilar in structure as the ULBPs, containing extracellular do-
mains with distant similarity to the 1 and 2 domains of the
MHC class I molecules, but contain a low level of sequence
conservation. Both of these proteins have been shown to in-
teract with the mouse NKG2D receptor (Cerwenka et al.,
2000; Diefenbach et al., 2001). More recently, two ULBP-
like transcripts have been identified in cattle and they have
been termed MHCLA1 and MHCLA2.
Human NKG2D also binds another class of MHC class
I-extended gene family members, namely the MHC-encoded
MICA and MICB proteins. These are also members of the
MHC class I gene superfamily but unlike ULBPs, MICA/B
contain 3 domains and are anchored to the membrane by
transmembrane domains (Vivier et al., 2002). MICA and
MICB are stress-inducible proteins whose expression is up-
regulated in certain tumors and infected cells (Groh et al.,
1996, 1999, 2001). Mice apparently lack orthologs of MICA
and MICB but the presence of MICA- and MICB-like genes
are clearly apparent in primates (Steinle et al., 1998; Seo et
al., 2001) and cattle (based on est sequences in GenBank). In
Sus scrofa (the pig), two MICA/B-like genes have been iden-
tified (dubbed MIC1 and MIC2) from genomic sequencing
efforts (Chardon et al., 2001). At least in the pig H01 haplo-
type, MIC1 appears to be a pseudogene while MIC2 seems
to possess features of a transcribed and functional MICA/B
gene (Chardon et al., 2001).
The molecular cloning of a porcine ULBP-like cDNA
and initial analysis of its functional properties are presented
here. The evolution of ULBP genes and genes encoding other
NKG2D ligands is an interesting aspect of the tailoring and
tuning of immune responses during mammalian speciation.
Characterization of genes encoding NKG2D ligands from
swine may have clinical ramifications as well given the doc-
umented role of human NK cells in the rejection of porcine
xenografts (Lin et al., 1997; Itescu et al., 1998). Ligands ex-
pressed by pig cells which are capable of interacting with
human NKG2D potentially could be targets to minimize hu-
man NK cell-mediated killing of porcine xenografts.
2. Materials and methods
2.1. DNA sequence analyses
Sequence data was edited and assembled using the Wis-
consin Package Version 10.3 (Accelrys Inc., San Diego, CA).
Alignments and sequence comparisons also were performed
using the Wisconsin Package. MEGA2 software (Kumar et
al., 2001) was employed to create a neighbor-joining tree us-
ing the proportion of synonymous and non-synonymous dif-
ferences of exons 2 and 3 sequences. Bootstrap trials (10,000
repetitions) were used to determine the statistical significance
of branches.
2.2. Southern blot analyses
Southern blot analyses were performed essentially as pre-
viously described (Crew et al., 1994). The probe was a 437 bp
fragment encompassing most of exons 2 and 3 (nucleotide
positions 172–609 of GenBank AY248037) which was 32P-
labeled using the Random Primer kit (Invitrogen, Carlsbad,
CA). Washing was at moderate stringency (45 ◦C, in 0.1×
SSC, 0.1% SDS).
2.3. RT-PCR for expression of porcine ULBP (PULBP)
and porcine MIC2 (PMIC2)
RNA from tissues of an approximately 30-day fetus (Large
White-Duroc hybrid) was isolated using TRIzol (Invitrogen).
RNA from AOC cells was extracted using RNeasy Mini Kit
(Qiagen Inc., Valencia, CA). First strand cDNA was syn-
thesized with SuperScript First-Strand Synthesis System for
RT-PCR (Invitrogen) using random primers. Two microliters
of the first strand cDNA were used to amplify the extracel-
lular domain-encoding sequence of PULBP and PMIC2 us-
ing gene specific primers (GACGATGGCGCAGACCGCT
and CGAATGGGCTATGGGGGGC for PULBP; GGTA-
CAACTTCACGGTGATGGCCC and CACGGCGTGGA-
CACTGTGATTCCC for PMIC2). PCR amplification of2m
used ATGATATCCCACTTTTCACACCGCTCCAGTAGC
and ATAGATCTGGATTCATCCAACCCAGATGCAGC as
primers. PCR products were run in a 1% agarose gel.
2.4. Porcine PBMC isolation and FACS analyses
Porcine PBMCs were isolated by standard protocols using
Ficoll-Hypaque density gradient centrifugation and mono-
cyte depletion by adherence to plastic. Genes encoding
PULBP-Fc (amino acids 1–219, seven amino acid linker, Fc
of human IgG1) and HUBLP2-Fc (amino acids 1–224, two
amino acid linker, Fc of human IgG1) fusion proteins under
control of the CMV Immediate-Early promoter were con-
structed by standard techniques and were expressed in COS-
1 cells. Cell-culture supernatants were concentrated by cen-
trifugation through Centriplus YM-10 columns (Millipore,
Bedford, MA) prior to use in FACS. PE-conjugated goat anti-
human IgG1 was employed as secondary antibody and was
purchased from Sigma–Aldrich (St. Louis, MO).
3. Results
3.1. Cloning of a porcine ULBP-like cDNA
No entries in the limited pig EST database (only ∼90,000
entries) exhibited similarity with human ULBPs. Therefore,
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Table 1
Degenerate primers used for porcine ULBP cDNA cloning
F1: 5′-GACVCWCACTSTCTYTKSTAYRACWTCA-3′
F2: 5′GTGGTGTGHRGTYCARRGCCWGG-3′
F3: 5′-TTTTCTYYMCTATGACTGTG-3′
R1: 5′-CATCCTKRCCTGCAGSGTSAGRGG-3′
R2: 5′-GAACTGCCARSATCCWCKGMYGTDTCC-3′
R3: 5′-TTCTCCCACTTBTCYKTCATC-3′
we used degenerate primers corresponding to conserved re-
gions in the human ULBP1, ULBP2, and ULBP3 (HULBP1-
3) gene sequences in initial attempts to amplify porcine ULBP
gene sequences. Three forward and three reverse degenerate
primers were synthesized (Table 1) and all nine combinations
were employed in PCR using pig genomic DNA from PK(15)
cells. Only F1/R2 and F1/R3 primer pairs yielded products of
the predicted sizes (data not shown). The F1/R3 PCR prod-
uct (the larger fragment) was sequenced and found to contain
segments with significant similarity to human ULBP1 and in-
cluded intron 2 (approximately 275 bp). Overlapping 5′ and
3′ portions of a full length porcine ULBP cDNA from the
MARC 1PIG cDNA library (Fahrenkrug et al., 2002) were
obtained using primers based upon the coding sequence of
this PCR product and these were subsequently ligated to yield
the final full length cDNA described here. The porcine ULBP
cDNA thus obtained was 1418 bp in length and contained
93 bp 5′ untranslated and 574 bp 3′ untranslated sequences
(GenBank accession number AY248037).
The predicted protein sequence encoded by the full length
porcine ULBP (PULBP) cDNA is shown in Fig. 1 and
is compared to HULBP1-4 protein sequences. The percent
amino acid identity between PULBP and each human ULBP
Table 2
Percent amino acid identity between PULBP and human ULBP proteins
1 2 All
ULBP1 52.3 49.5 44.5
ULBP2 48.9 45.2 39.7
ULBP3 43.2 50.5 42.1
ULBP4 35.2 43.0 35.2
(Table 2) is comparable to the percent amino acid identities
between each human ULBP (Cosman et al., 2001). PULBP
is predicted to be GPI-linked (using DGPI on the ExPASy
proteomics server) with a cleavage site (Fig. 1) at approx-
imately the same relative location as HULBP1-3 (Cosman
et al., 2001). The 14 residues of ULBP3 which make con-
tact with NKG2D (Radaev et al., 2002) are relatively well
conserved in PULBP—five are identical and three are con-
servative substitutions (Fig. 1). However, considering all the
human ULBPs, 11 of the 14 residues are found in at least one
of the other human ULBPs (Fig. 1).
3.2. Phylogenetic analyses of mammalian ULBP-like
genes
The DNA sequences encoding the 1 and 2 domains of
PULBP, HULBP1-4, two cattle ULBP-like gene sequences
(MHCLA1 andMHCLA2, Larson et al., 2003), and the natural
ligand for the murine NKG2D receptor, Raet1, were used to
examine the phylogenetic relationship of mammalian ULBP-
like genes. A neighbor-joining tree is shown in Fig. 2. PULBP
branched more closely to the bovine ULBP-like genes,
MHCLA1 and MHCLA2. Identical tree topologies were
Fig. 1. Alignment of the predicted protein sequence of porcine ULBP (PULBP) with human ULBP protein sequences. The predicted peptide sequence of
porcine ULBP (PULBP) is aligned with those of human ULBP1–4 where dashes (-) indicate identity to PULBP and alignment gaps are indicated by periods (·).
Contact residues between human ULBP3 and human NKG2D (Radaev et al., 2002) are shaded. Conservative substitutions and non-conservative substitutions
in these residues of PULBP with respect to all other human ULBPs are indicated by filled circles () and open circles (©), respectively. The predicted cleavage
site of PULBP for GPI-linkage is noted with an arrow. Potential N-linked glycosylation sites in PULBP are underlined and in bold.
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Fig. 2. Phylogenetic analysis of mammalian ULBP coding sequences. A neighbor-joining tree using the proportion (p) of synonymous and non-synonymous
differences of ULBP exons 2 and 3 sequences (encoding the 1 and 2 domains) is shown. The scale of p relative to branch lengths is given by the bar below
the tree. Interior branches with a bootstrap confidence level of greater than 95% are indicated by an asterisk. Human ULBP1-3 sequences were obtained from
GenBank accession numbers AF304377, AF304378, AF304379, human ULBP4 from AY252119, bovine ULBP-like DNAs (MHCLA1 and MHCLA2) from
AY160681 and AF371556, and mouse Raet1 from NM 009016.
observed using a wide assortment of distance matrices. In-
terestingly, human ULBP4 branched outside of an intuitive
human, bovine, and porcine ULBP-like gene clade suggest-
ing that it may be of ancient origin.
3.3. Gene copy number of porcine ULBP-like genes
Southern blot analysis of pig genomic DNA was under-
taken to roughly approximate the size of the porcine ULBP
gene family. Using a 437 bp probe (which based on human
ULBP genomic sequences, was predicted to contain most of
exons 2 and 3) and moderate stringency conditions, a single
band was observed with three different restriction enzymes
(Fig. 3). Identical results were obtained using the full-length
cDNA as probe (data not shown). These results suggest that
perhaps there is only one ULBP gene in the pig genome. If
there is another ULBP gene in pigs, it is likely to be highly
divergent from the PULBP sequence reported here. PCR stud-
ies using degenerate primers (Table 1) is consistent with this
assertion—while several pairs of these were able to amplify
at least three human ULBP gene sequences (data not shown),
only one porcine ULBP-like gene was identified.
3.4. Expression of the potential porcine NKG2D
ligands, PULBP and PMIC2
The tissue distribution of PULBP mRNA transcripts was
examined by RT-PCR. Such analyses revealed that PULBP
is widely expressed with appropriately spliced transcripts
detectable in all tissues examined except brain (Fig. 4A).
The intestine appeared to have the highest levels of PULBP
transcripts among the tissues examined. The expression of
porcine MIC2 (PMIC2), another potential NKG2D ligand,
was also examined in the same tissues. The sequence of
PMIC2 has been previously reported (Chardon et al., 2001)
but not its expression pattern. Unlike PULBP, RT-PCR anal-
yses shows that pig MIC2 has a slightly more limited tissue
distribution with transcripts detected in heart, intestine, kid-
ney, muscle, liver, lung, testes, and thymus (Fig. 4A). PMIC2
transcripts were not detected in PBMC or spleen.
Basal and inducible expression of PULBP and PMIC2 was
also examined in AOC cells, a porcine aortic endothelial cell
line (Carrillo et al., 2002). Although not a quantitative assay,
Fig. 3. Southern blot analysis of porcine ULBP gene copy number. Pig
genomic DNA (20g, from LLC-PK1 cells) cleaved with BamHI, EcoRI,
orHindIII (lanes 1–3, respectively), was analyzed by Southern blotting using
a 437 bp fragment of PULBP cDNA as a probe as described in Section 2.
Positions corresponding to migration of DNA size standards (in kbs) are
noted at the left of the autoradiogram.
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Fig. 4. Expression of potential porcine ligands for NKG2D. (A) Tissue distribution of PULBP and PMIC2 transcripts. Gene-specific primers for PULBP,
PMIC2, and 2m were used in PCR using first strand cDNA reverse transcribed from RNA of the indicated pig tissues. The size of correctly spliced transcripts
is indicated at the right. (B) Inducible expression of PULBP in a porcine aortic endothelial cell line. RT-PCR using primers specific for pig ULBP, MIC2, and,
as a control, 2m (as indicated at the left) was carried out using RNA from control cells or cells induced with heat shock (42 ◦C for 90 min) or 1 uM all-trans
retinoic acid (as indicated above the lanes). Primers for PULBP amplification were CGATACTCACTCTCTTTGC and CGCTGTCTTCAACATTTTCTCCC.
The predicted size of correctly spliced cDNA (indicated at the right) was observed in all nine RT-PCR reactions.
PMIC2 transcript levels appeared to be increased by both
heat shock and retinoic acid (Fig. 4B) PULBP expression,
though readily detectable in AOC cells, appeared unaffected
by either treatment (Fig. 4B).
3.5. Binding of PULBP-Fc recombinant protein to pig
PBMCs
As a first step in the functional characterization of PULBP,
we sought to determine whether the PULBP protein is able
to bind a subset of lymphocytes as does its human orthologs
and whether PULBP is able to bind human NKG2D. To this
end a gene encoding a PULBP-Fc (IgG1) fusion protein was
constructed and expressed in COS-1 cells. The media from
such cultures was concentrated and used for FACS analyses
of porcine PBMCs and a human NK cell line, NKL cells
(chosen because they uniformly express NKG2D). A human
ULBP2-Fc fusion protein was examined as well. As a nega-
tive control, cell culture supernatants from COS-1 cells ex-
pressing a GFP-Fc fusion protein were employed. The results,
shown in Fig. 5, suggests that PULBP is able to bind a portion
of porcine PBMCs although the nature of this subset could
Fig. 5. Binding of PULBP-Fc fusion protein to porcine PBMCs. FACS anal-
yses of porcine PBMCs and a human NK cell line (NKL cells) using a
GFP-Fc fusion protein (as negative control), PULBP-Fc, and HULBP2-Fc
(indicated at the right of the histograms) are shown.
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not be determined because of the lack of appropriate anti-
bodies to porcine cell-surface markers. Interestingly, human
ULBP2 exhibited no binding to porcine PBMCs. Conversely,
no binding to NKL cells was observed with PULBP-Fc al-
though binding of HULBP2-Fc to NKL cells was quite evi-
dent (Fig. 5).
4. Discussion
We have cloned a porcine homolog of human ULBPs de-
noted here as PULBP. PULBP exhibits 35–52% amino acid
identity to human ULBPs (Table 1) and phylogenetic anal-
yses places PULBP in close evolutionary relationship to the
bovine ULBP-like genes MHCLA1 and MHCLA2 (Fig. 2).
Scrutiny of the predicted PULBP amino acid sequence with
respect to residues making contact with NKG2D (Radaev et
al., 2001) revealed a relatively high level of amino acid con-
servation at these positions (Fig. 1).
Southern blot results (Fig. 3) suggest that only one PULBP
exists in the pig genome. Even at low stringency hybridiza-
tion using full-length PULBP as probe, only one band was
observed. We conclude that if other ULBP-like genes exist
in the pig genome, they are significantly divergent from the
PULBP cDNA described here. If, in fact, there is only one
porcine ULBP gene and the pseudogene features of porcine
MIC1 in the H01 haplotype (Chardon et al., 2001) are found
in all pig haplotypes, then the pig apparently expresses only
two NKG2D ligands. This is in sharp contrast to the at least
six expressed by humans.
Similar to human ULBPs, transcripts of PULBP were ob-
served in a variety of tissues (Fig. 4A). The relatively high
level of PMIC2 expression observed in the intestine (Fig. 4A)
is consistent with previous studies of human MICA/B as well
(Groh et al., 1996). Furthermore, human MICA/B are in-
ducible by heat shock and retinoic acid (Groh et al., 1996;
Jinushi et al., 2003) and PMIC2, but not PULBP, transcripts
were increased by these treatments as well (Fig. 4B). Whether
or not the presence of PULBP or PMIC2 transcripts is indica-
tive of cell-surface expression must await the development of
antibodies specific for these proteins.
A striking aspect of ligands for human NKG2D is their di-
versity both in terms of sequence variation and domain com-
position. An induced fit model, whereby NKG2D adopts lo-
cal conformational changes upon ligand interaction, has been
proposed as the structural basis for the ability of NKG2D to
bind such a diverse array of ligands (Radaev et al., 2001).
Using the crystal structure coordinates of NKG2D com-
plexed with different ligands, Radaev et al. (2002) devel-
oped an algorithm to score potential ligands of NKG2D
(http://red.niaid.gov/programs). The receptor:ligand algo-
rithm evaluates abilities to form interface salt bridges, hy-
drogen bonds, and hydrophobic interactions, calculates the
solvent accessibility weighted energetic contribution of each
interface residue, and then figures ligand compatibility for the
NKG2D receptor based on a mutational matrix. Two different
templates of the interface can be assumed in the algorithm,
one using the human ULBP3/NKG2D coordinate data and
the other using the coordinates of the mouse Rae1b/NKG2D
structure. Using this algorithm with the ULBP3 template,
PULBP scored higher than human ULBP1 and ULBP2 (data
not shown) suggesting that PULBP is a compatible ligand
for human NKG2D. It was, therefore, surprising to observe
that PULBP, although capable of binding porcine PBMCs,
was unable to bind to human NK cells and that human
ULBP2 which was able to bind human NK cells could not
stably interact with porcine PBMCs (Fig. 5). Thus, while
human NKG2D can be considered promiscuous in ligand
binding, this promiscuity apparently does not extend across
species. PULBP has three potential N-linked glycosylation
sites (Fig. 1), one of which corresponds to an amino acid
that is important in the interaction between human NKG2D
and ULBP3 (Radaev et al., 2002). It is possible that this gly-
cosylation could prevent the binding of PULBP to human
NKG2D.
Pig NKG2D has 67% amino acid identity with human
NKG2D (Yim et al., 2002) and we propose that the cross-
species difference in NKG2D primary structure accounts for
the cross-species incompatibility of ULBP-NKG2D interac-
tion. Whether this incompatibility extends to other NKG2D
ligands, other human ULBPs or MIC-like proteins, is cur-
rently under investigation. An mAb against human NKG2D
substantially blocked human NK cell-mediated lysis of a
porcine aortic endothelial cell line (unpublished data) sug-
gesting that there is at least one pig NKG2D ligand capable
of binding to human NKG2D.
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